Related Experiment Video
Updated: Feb 15, 2026

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
Published on: March 8, 2018
Implementing genome-driven personalized cardiology in clinical practice
1Consulting Professor of Surgery, Emeritus Faculty of Surgery and of Biomedical Engineering, Duke University School of Medicine and Graduate School, Durham, NC 27710, USA.
Genomics offers personalized cardiology approaches for complex cardiovascular diseases (CVDs), integrating genetic data with clinical insights for tailored prevention and treatment. Future advances promise to further refine these genome-driven strategies for improved patient outcomes.
Area of Science:
- Cardiovascular Genomics
- Precision Medicine
- Molecular Cardiology
Background:
- Complex cardiovascular diseases (CVDs) involve intricate interactions between multiple genomic variants, epigenetics, and environmental factors.
- Understanding the genomics of CVDs like cardiomyopathies, arrhythmias, and heart failure is challenging due to non-linear genotype-phenotype relationships.
- Electronic medical/health records (EMRs/EHRs) incorporating genomic data create a powerful network for research and clinical application.
Purpose of the Study:
- To survey current concepts and breakthroughs in cardiovascular genomics.
- To highlight the potential of genome-driven personalized cardiology in clinical practice.
- To discuss the integration of genomics with epigenetics and environmental factors for CVD management.
Main Methods:
- Leveraging multimodal electronic medical/health records (EMRs/EHRs) with genomic information.
- Analyzing complex interactions between genetic variants, epigenetics, and environmental risk factors.
- Utilizing high-throughput genomic technologies for precise diagnosis and treatment.
Main Results:
- Genomics enables insights into pathogenetic pathways, biomarker-assisted diagnosis, and prognosis stratification for CVDs.
- Personalized cardiology, complementing traditional guidelines, offers customizable CVD prevention, diagnosis, and management.
- Emerging therapies include stem cell and gene therapies (e.g., CRISPR-Cas9) and metabolomic-pharmacogenomic modalities.
Conclusions:
- Genome-driven personalized cardiology provides crucial clinical benefits by targeting causal defects at the molecular and cellular levels.
- While genotype does not equal phenotype, integrating genomic data with clinical information is essential for effective application.
- Future genomic advancements, combined with epigenetic and environmental insights, hold the potential to significantly impact CVD eradication and improve human health.
Related Concept Videos
Genomics
Nursing Implementation
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Genome Size and the Evolution of New Genes
Personal Identity
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...

